Enspectra Health Announces US FDA Clearance of VIO™ System, First of Its Kind Technology to Visualize Skin Cellular Structures in Real-Time
MOUNTAIN VIEW, Calif., Jan. 3, 2024 /PRNewswire/ — Enspectra Health, a health tech company, announces US FDA 510(k) clearance of the VIO System, launching a new era in noninvasive imaging. VIO, the first of its kind technology, combines reflectance confocal and multiphoton microscopy to enable cellular resolution, cross-sectional imaging of skin in seconds. Easily portable and handheld, VIO digitizes pathology directly from a patient’s skin to provide clinical insights for physicians.
